Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 123,837	$ 188,480
Short-term investments	145,861	130,291
Restricted cash (SRX Cardio)	172	178
Prepaid research and development	3,487	7,299
Prepaid expenses and other current assets	12,330	2,680
Total current assets	285,687	328,928
Property and equipment, net	5,576	6,143
Intangible assets	8,151	3,151
Prepaid and other long-term assets	6,277	5,214
Total assets	305,691	343,436
Current liabilities:
Accounts payable	11,938	14,546
Accrued compensation and employee benefits	5,560	4,806
Accrued research and development	22,050	23,818
Accrued and other liabilities	3,038	1,696
Deferred revenue, current portion	15,187	20,798
Total current liabilities	57,773	65,664
Notes payable, long-term	51,627	49,815
Long term debt	50,117
Long term obligation to Collaborator	8,000	8,000
Deferred revenue, long-term	21,661	24,965
Other long-term liabilities	3,146	2,303
Total liabilities	192,324	150,747
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.001 par value, 100,000,000 shares authorized at June 30, 2017 and December 31, 2016; 57,576,731 shares and 56,544,218 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively	59	57
Additional paid-in capital	1,140,660	1,108,832
Accumulated deficit	(1,029,634)	(918,345)
Accumulated other comprehensive loss	(70)	(12)
Total Portola stockholders’ equity	111,015	190,532
Noncontrolling interest (SRX Cardio)	2,352	2,157
Total stockholders’ equity	113,367	192,689
Total liabilities and stockholders’ equity	$ 305,691	$ 343,436